Mometasone Furoate Market
- 2026 年市場規模
- USD 1,582.6 Mn
- 2033 年預估規模
- USD 2,608.0 Mn
- 年複合成長率 CAGR
- 7.4%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Mometasone Furoate Market, By Dosage form (Nasal Spray, Cream, Ointment, Inhalers, Others (Topical Solutions, etc.)), By Indication (Inflammatory Skin Disorders, Asthma, Allergic rhinitis, Others (Hay Fever, etc.)), By Route of Administration (Nasal Administration, Topical, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Mometasone furoate topical is effective at reducing the redness, itching, swelling, and other pain caused by several skin conditions. Mometasone furoate is a corticosteroid drug also used to treat asthma and it is an effective treatment for a variety of skin allergies as well as other allergic conditions like hay fever and allergic rhinitis.
Market Dynamics
Increasing prevalence of asthma worldwide is expected to witness significant growth in forecast period. For instance, according to the World Health Organization (WHO), in 2019, 455 000 individuals died from asthma and an estimated 262 million people were affected by asthma worldwide. Asthma is widely misdiagnosed and poorly managed, particularly in low- and middle-income countries. In most severe cases, asthma can be fatal.
Increasing product launches and approvals by market players are expected to drive growth of the global mometasone furoate market over the forecast period. For instance, in April 2017, Amneal Pharmaceuticals LLC, a U.S.-based, publicly traded generics and specialty pharmaceutical company launched Mometasone furoate nasal spray, the first pharmaceutical product that Amneal Pharmaceuticals LLC had produced in spray form. Nasonex is therapeutic equivalent of mometasone furoate and is offered in 50 mcg/spray strength.
Increasing research and development activities related to mometasone furoate are expected to drive growth of market over the forecast period. For instance, according to an article published in Medicine, medical journal, in December 2019, a study was performed on patients with head and neck squamous cell carcinoma (HNSCC) to check efficacy of local application of mometasone furoate in reducing acute radiation dermatitis (ARD) in China. Patients were divided into two groups, test groups and control groups. The patients in test groups were given mometasone furoate once daily from the start of their radiotherapy until the test side skin acquired ARD lesions, and patients in control groups, were given no treatment at all. The study showed that, mometasone furoate inunction after high dose radiotherapy can prevent acute radiation dermatitis (ARD).
Key features of the study
• This report provides an in-depth analysis of the global mometasone furoate market, market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains an attractive investment proposition matrix for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global mometasone furoate market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
• Key companies covered as a part of this study include include Cipla, Teva Pharmaceuticals, Glenmark Pharmaceuticals, AdvaCare Pharma, Medlab Pharmaceuticals Private Limited, Dermocare Laboratories, Iva Healthcare Private Limited, Unilab Chemicals & Pharmaceuticals Pvt Ltd, Organon group of companies, Cosette Pharmaceuticals, Taro Pharmaceutical Industries Ltd., and Hikma Pharmaceuticals
• Insights from this report would allow marketers and the management authorities of the companies to make an informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
• The global mometasone furoate market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global mometasone furoate market
Market Segmentation
• Global Mometasone Furoate Market, By Dosage form
o Nasal Spray
o Cream
o Ointment
o Inhalers
o Others (Topical Solutions, etc.)
• Global Mometasone Furoate Market, By Indication
o Inflammatory Skin Disorders
o Asthma
o Allergic rhinitis
o Others (Hay Fever, etc.)
• Global Mometasone Furoate Market, By Route of Administration
o Nasal Administration
o Topical
o Oral
• Global Mometasone Furoate Market, By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• Global Mometasone Furoate Market, By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Global Mometasone Furoate Market, Key Players
o Cipla
o Teva Pharmaceuticals
o Glenmark Pharmaceuticals
o AdvaCare Pharma
o Medlab Pharmaceuticals Private Limited
o Dermocare Laboratories
o Iva Healthcare Private Limited
o Unilab Chemicals & Pharmaceuticals Pvt Ltd
o Organon group of companies
o Cosette Pharmaceuticals
o Taro Pharmaceutical Industries Ltd.
o Hikma Pharmaceuticals.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Dosage form
Market Snippet, By Indication
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Porter’s Analysis
o Industry Trends
o Key Highlights
o Epidemiology
o Reimbursement Scenario
o Regulatory Scenario
o Product Launch and Approvals
o Acquisition and Collaboration Scenario
4. Global Mometasone Furoate Market, By Dosage Form, 2026-2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026-2033
Segment Trends
o Nasal spray
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Cream
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Ointment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Inhalers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
5. Global Mometasone Furoate Market, By Indication, 2026-2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026-2033
Segment Trends
o Inflammatory skin disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Asthma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Allergic rhinitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
6. Global Mometasone Furoate Market, By Route of Administration, 2026-2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026-2033
Segment Trends
o Nasal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
7. Global Mometasone Furoate Market, By Distribution Channel, 2026-2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026-2033
Segment Trends
o Hospitals Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
8. Global Mometasone Furoate Market, By Region, 2026-2033 (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2026-2033
Regional Trends
o North America
Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
Market Size and Forecast, By Country, 2026-2033 (USD Mn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
Market Size and Forecast, By Country, 2026-2033 (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
Market Size and Forecast, By Country, 2026-2033 (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
Market Size and Forecast, By Country, 2026-2033 (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
Market Size and Forecast, By Country, 2026-2033 (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Dosage Form, 2026-2033 (USD Mn)
Market Size and Forecast, By Indication, 2026-2033 (USD Mn)
Market Size and Forecast, By Route of Administration, 2026-2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2026-2033 (USD Mn)
Market Size and Forecast, By Country/Region, 2026-2033 (USD Mn)
o South Africa
o Central Africa
o North Africa
9. Competitive Landscape
o Company Profiles
Cipla
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Teva Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Glenmark Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
AdvaCare Pharma
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Medlab Pharmaceuticals Private Limited
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Dermocare Laboratories
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Iva Healthcare Private Limited
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Unilab Chemicals & Pharmaceuticals Pvt Ltd
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Organon group of companies
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Cosette Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Taro Pharmaceutical Industries Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
Hikma Pharmaceuticals.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Strategies
o Analyst Views
10. Section
o Research Methodology
o About us
o Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們